A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
PHASE1CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
January 31, 2006
Study Completion Date
November 30, 2006
Conditions
Chronic Kidney DiseaseAnemia
Interventions
DRUG
epoetin alfa
All Listed Sponsors
collaborator
Centocor Ortho Biotech Services, L.L.C.
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00641589 - A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter